Cargando…
Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
BACKGROUND: Probiotics are a promising solution for managing irritable bowel syndrome (IBS). Saccharomyces cerevisiae (S. cerevisiae) I-3856 has already demonstrated beneficial effects in IBS subjects, particularly in IBS with predominant constipation (IBS-C). AIM: To confirm the efficacy of S. cere...
Autores principales: | Mourey, Florian, Decherf, Amélie, Jeanne, Jean-François, Clément-Ziza, Mathieu, Grisoni, Marie-Lise, Machuron, François, Legrain-Raspaud, Sophie, Bourreille, Arnaud, Desreumaux, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258277/ https://www.ncbi.nlm.nih.gov/pubmed/35979259 http://dx.doi.org/10.3748/wjg.v28.i22.2509 |
Ejemplares similares
-
Recovery of Saccharomyces cerevisiae CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration
por: Decherf, Amelie, et al.
Publicado: (2020) -
Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis
por: Cayzeele-Decherf, Amélie, et al.
Publicado: (2017) -
Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
por: Spiller, Robin, et al.
Publicado: (2015) -
Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs
por: Harvie, Ruth M, et al.
Publicado: (2017) -
Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease
por: Pedersen, Natalia, et al.
Publicado: (2017)